Evaluation of Glomerular Filtration Rate in Dogs with Renal Disease Using Serum Cystatin C
World Small Animal Veterinary Association World Congress Proceedings, 2003
R. Gonul; A. Kayar; M.E. Or; I. Kahraman
Department of Internal Medicine, Veterinary Faculty, Istanbul University
Avcilar-Istanbul, Turkey

Objectives

Assessment of renal function in patients with renal disease has a great importance. Various studies have reported about cystatin C as an easy and rapid assessable marker that can be used for accurate information on renal function impairment in humans lastly, but we have found only one study in dogs.

Material & Methods

For this reason in this study, the glomerular filtration rate (GFR) of 30 dogs of different breeds with a broad range of bodyweight were evaluated by using serum cystatin C to determine its usefulness as a marker. Ten dogs which formed the control group, and 20 dogs which had elevated serum creatinine levels and a low urine specific gravity due to renal disease, constituted the study material.

Results

The range of serum cystatin C values was 1,2±0,42 mg/L in control dogs, 2,96±1,09 mg/L in dogs with azotaemic renal disease (p<0,01).

Conclusion

The study indicates that, endogenous markers of GFR are more advantageous such as cheap and simple, and more accurate, rapid and reliable tool for evaluating GFR in small animal practice.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

R. Gonul
Department of Internal Medicine, Veterinary Faculty, Istanbul University
Avcilar-Istanbul, Turkey


MAIN : Oral Presentations : Serum Cystatin C
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27